noodls browser compatibility check

The security settings of your browser are blocking the execution of scripts.

To use noodls, javascript support must be enabled. Please change your browser's security settings to enable javascript.

If you have changed your browser's security settings, you can click here.

related announcements

Science

Saladax Biomedical Inc

Health Canada Approves Saladax’s 5-Fluorouracil Chemotherapy[...]
Immunomic Therapeutics Inc

ITI’s Poster Presentation at SITC 39th Annual Meeting 2024
MIT - Massachusetts Institute of[...]

How the biggest Alzheimer’s risk gene disrupts the process of[...]

Company News

Immunomic Therapeutics Inc

01/23/2023 | Press release | Archived content

2023 Cell and Gene Therapy on the Mesa, October 10-12, Carlsbad, CA

This meeting will feature in-person presentations by leading public and private companies, highlighting technical and clinical achievements over the past 12 months in the areas of cell therapy, gene therapy, gene editing, tissue engineering and broader regenerative medicine technologies.

Immunomic Therapeutics Inc published this content on January 23, 2023, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on November 02, 2026 at 11:07 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]

Back

View original format